Janus kinase inhibitors for alopecia areata

JAKis have forever changed AA, providing the first two approved medicines, baricitinib and ritlecitinib, for severe AA, with not only other JAKis but hopefully other treatments with novel mechanisms of action to follow. These advances portend a bright future for patients.